MX9302165A - Derivados de benzoxazinona y benzothiazinona y composiciones farmaceuticas que los comprende - Google Patents
Derivados de benzoxazinona y benzothiazinona y composiciones farmaceuticas que los comprendeInfo
- Publication number
- MX9302165A MX9302165A MX9302165A MX9302165A MX9302165A MX 9302165 A MX9302165 A MX 9302165A MX 9302165 A MX9302165 A MX 9302165A MX 9302165 A MX9302165 A MX 9302165A MX 9302165 A MX9302165 A MX 9302165A
- Authority
- MX
- Mexico
- Prior art keywords
- carbon atoms
- benzoxazinone
- pharmaceutical compositions
- dihydro
- nitro
- Prior art date
Links
- MJNPHLBKHKJDEF-UHFFFAOYSA-N 2h-1$l^{4},2-benzothiazine 1-oxide Chemical class C1=CC=C2S(=O)NC=CC2=C1 MJNPHLBKHKJDEF-UHFFFAOYSA-N 0.000 title 1
- HQQTZCPKNZVLFF-UHFFFAOYSA-N 4h-1,2-benzoxazin-3-one Chemical compound C1=CC=C2ONC(=O)CC2=C1 HQQTZCPKNZVLFF-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 6
- -1 hydroxy-substituted phenyl Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- PLGGWNRXUVCKEK-UHFFFAOYSA-N 2,3-dihydro-1,3-benzothiazin-4-one Chemical compound C1=CC=C2C(=O)NCSC2=C1 PLGGWNRXUVCKEK-UHFFFAOYSA-N 0.000 abstract 1
- YBYIZRPBXCCDQW-UHFFFAOYSA-N 2,3-dihydro-1,3-benzoxazin-4-one Chemical compound C1=CC=C2C(=O)NCOC2=C1 YBYIZRPBXCCDQW-UHFFFAOYSA-N 0.000 abstract 1
- 150000008043 acidic salts Chemical class 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 150000001447 alkali salts Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000002993 cycloalkylene group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
- C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Control Of Transmission Device (AREA)
- Optical Filters (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describen las 2,3-dihidro-4H-1,3-benzoxazin-4-onas y las 2,3-dihidro-4H-1,3-benzotiazin-4-onas de la fórmula I en donde R representa hidrógeno, alquilo de I a 6 átomos de carbono, cicloalquilo de 5 a 7 átomos de carbono, fenilo, fenilo sustituido por hidroxi, halógeno, nitro, alquilo de 1 a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono, metilendioxi; R1 y R2 independientemente representan hidrógeno, amida, amino, carboxi, hidroxi, nitro, ciano, mercapto; X es un átomo de oxígeno o azufre, Y es una cadena de alquileno de 2 a 6 átomos de carbono o un grupo cicloalquileno de 2 a 6 átomos de carbono; y las sales ácidas o básicas farmacéuticamente aceptable de las mismas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI920940A IT1254884B (it) | 1992-04-16 | 1992-04-16 | Benzossazinoni e benzotiazinoni ad attivita' cardiovascolare |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9302165A true MX9302165A (es) | 1993-10-01 |
Family
ID=11362985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9302165A MX9302165A (es) | 1992-04-16 | 1993-04-14 | Derivados de benzoxazinona y benzothiazinona y composiciones farmaceuticas que los comprende |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5480882A (es) |
| EP (1) | EP0566018B1 (es) |
| JP (1) | JP3257716B2 (es) |
| CN (1) | CN1078466A (es) |
| AT (1) | ATE169293T1 (es) |
| AU (1) | AU655540B2 (es) |
| CA (1) | CA2092342A1 (es) |
| DE (1) | DE69320087T2 (es) |
| FI (1) | FI931688A (es) |
| HU (1) | HUT68605A (es) |
| IL (1) | IL105158A (es) |
| IT (1) | IT1254884B (es) |
| MX (1) | MX9302165A (es) |
| NO (1) | NO931225L (es) |
| NZ (1) | NZ247249A (es) |
| TW (1) | TW288013B (es) |
| ZA (1) | ZA932030B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1264812B1 (it) * | 1993-07-28 | 1996-10-10 | Italfarmaco Spa | Derivati benzossazinonici e benzotiazinonici terapeuticamente attivi |
| WO2001004103A1 (en) * | 1999-07-13 | 2001-01-18 | F. Hoffmann-La Roche Ag | Benzazepinones and quinazolines |
| CA2419838A1 (en) | 2000-08-31 | 2003-02-18 | Takeda Chemical Industries, Ltd. | Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| JP5700547B2 (ja) | 2011-05-30 | 2015-04-15 | 国立大学法人京都大学 | バイオチップ形成用感光性樹脂組成物、及びバイオチップ |
| CN102367239B (zh) * | 2011-07-20 | 2015-10-28 | 沈阳药科大学 | 2-芳基-2,3-二氢-4h-1,3-苯并噻嗪-4-酮衍生物及其用途 |
| CN103012188A (zh) * | 2011-09-20 | 2013-04-03 | 北京京卫信康医药科技发展有限公司 | 一种龙胆酸乙醇胺的制备方法 |
| CN102631108A (zh) * | 2012-04-25 | 2012-08-15 | 张家港市立达金属制品有限公司 | 帽子展示架 |
| ITMI20122221A1 (it) * | 2012-12-21 | 2014-06-22 | C4T S C A R L | Nuovi composti del 2,3-diidro-4h-1,3-benzossazin-4-one, metodo per prepararli e forma farmaceutica che li comprende |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3539563A (en) * | 1965-09-27 | 1970-11-10 | Istituto Chemioterapico | Tetracycline: 6-amino-4-oxo-2-(beta-chloroethyl) - 2,3 - dihydrobenzene - 1,3-oxazine double salt dihydrate |
| US3459748A (en) * | 1967-04-28 | 1969-08-05 | Squibb & Sons Inc | Hydroxyalkylene-substituted benzoxazines and benzothiazines |
| FR2636065B1 (fr) * | 1988-09-08 | 1993-05-07 | Fabre Sa Pierre | Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique |
| IT1244472B (it) * | 1990-12-14 | 1994-07-15 | Italfarmaco Spa | Benzossazinoni e benzotiazinoni ad attivita' cardiovascolare |
-
1992
- 1992-04-16 IT ITMI920940A patent/IT1254884B/it active IP Right Grant
-
1993
- 1993-03-22 ZA ZA932030A patent/ZA932030B/xx unknown
- 1993-03-24 IL IL10515893A patent/IL105158A/en not_active IP Right Cessation
- 1993-03-24 CA CA002092342A patent/CA2092342A1/en not_active Abandoned
- 1993-03-25 NZ NZ247249A patent/NZ247249A/xx unknown
- 1993-03-30 AU AU35617/93A patent/AU655540B2/en not_active Ceased
- 1993-03-31 NO NO93931225A patent/NO931225L/no unknown
- 1993-04-07 DE DE69320087T patent/DE69320087T2/de not_active Expired - Fee Related
- 1993-04-07 EP EP93105752A patent/EP0566018B1/en not_active Expired - Lifetime
- 1993-04-07 AT AT93105752T patent/ATE169293T1/de active
- 1993-04-14 FI FI931688A patent/FI931688A/fi not_active Application Discontinuation
- 1993-04-14 TW TW082102853A patent/TW288013B/zh active
- 1993-04-14 MX MX9302165A patent/MX9302165A/es unknown
- 1993-04-15 JP JP11214993A patent/JP3257716B2/ja not_active Expired - Fee Related
- 1993-04-15 HU HU9301106A patent/HUT68605A/hu unknown
- 1993-04-16 CN CN 93104624 patent/CN1078466A/zh active Pending
-
1994
- 1994-11-23 US US08/347,217 patent/US5480882A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3257716B2 (ja) | 2002-02-18 |
| EP0566018B1 (en) | 1998-08-05 |
| FI931688A0 (fi) | 1993-04-14 |
| AU655540B2 (en) | 1994-12-22 |
| EP0566018A3 (en) | 1994-06-01 |
| ITMI920940A0 (it) | 1992-04-16 |
| DE69320087D1 (de) | 1998-09-10 |
| ATE169293T1 (de) | 1998-08-15 |
| HUT68605A (en) | 1995-06-28 |
| DE69320087T2 (de) | 1998-12-10 |
| IL105158A (en) | 1996-10-31 |
| ZA932030B (en) | 1993-10-19 |
| FI931688A (fi) | 1993-10-17 |
| HU9301106D0 (en) | 1993-07-28 |
| NO931225L (no) | 1993-10-18 |
| NO931225D0 (no) | 1993-03-31 |
| ITMI920940A1 (it) | 1993-10-16 |
| EP0566018A2 (en) | 1993-10-20 |
| AU3561793A (en) | 1993-10-21 |
| TW288013B (es) | 1996-10-11 |
| US5480882A (en) | 1996-01-02 |
| NZ247249A (en) | 1995-01-27 |
| JPH0625194A (ja) | 1994-02-01 |
| CA2092342A1 (en) | 1993-10-17 |
| CN1078466A (zh) | 1993-11-17 |
| IT1254884B (it) | 1995-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9204746A (es) | Nuevos derivados de tiazolilbenzofuranos, procedimientos para la preparacion de los mismos y las composiciones farmaceuticas que los contienen. | |
| CO4970713A1 (es) | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen | |
| FI885332A (fi) | 3-/4-(-1-substituerad-4-piperazinyl) butyl/-4-tiazolidinoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| ES2054057T3 (es) | Derivados de (aza)naftalenosultamo, sus procedimientos de preparacion y los medicamentos que les contienen. | |
| MX9302165A (es) | Derivados de benzoxazinona y benzothiazinona y composiciones farmaceuticas que los comprende | |
| DK327286D0 (da) | Indolcarboxamidderivater og salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter til deres fremstilling | |
| DK0803503T3 (da) | Syrer og estere af diosmetin og pharmaceutiske sammensætninger indeholdende disse | |
| MX9102540A (es) | Derivados de benzoxazinona y benzotiazinona, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| DK0812835T3 (da) | Optisk aktive thiazolidinonderivater | |
| ES2183434T3 (es) | Derivados de cromano sustituidos con carboxilo utiles como agonistas de adrenoreceptores. | |
| FI833784A0 (fi) | 1,3,4,6,7,11b-hexahydro-7-aryl-2h-pyrazino/2,1-a/isokinoliner och foerfaranden foer framstaellning dessa | |
| DE69835966D1 (de) | Medizinische anwendungen von phenylalkanolen und derivaten davon | |
| PE20020610A1 (es) | Compuestos hidroxietilamina tripeptidos mimeticos como inhibidores de la aspartil proteasa de vih | |
| EA200200462A1 (ru) | Производные 2-арилхинолина, их получение и терапевтическое применение | |
| ECSP982756A (es) | Derivados de acido hidroxamico como inhibidores de metalproteasas de matriz (mmp) | |
| ECSP920822A (es) | Composiciones heterocyclicas | |
| FI945762A (fi) | Uudet 3-okso-1,4-bentsotiatsiinijohdannaiset |